Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 2, 2015
Patent Application Number
13787877
Date Filed
March 7, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to novel peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. The invention also encompasses the use of the said therapeutic agents and derivatives for treatment of disorders via immunopotentiation comprising inhibition of immunosuppressive signal induced due to PD-1, PD-L1, or PD-L2 and therapies using them.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
